Regenxbio Overview
Regenxbio Target Price
Analysts' 12-month price predictions for RGNX.
Get informed when a big investor buys or sells
+ FollowShare Price
$12.29
Average Target Price
$20.80
69.2% upside
69.2% upside5 analysts in the last 4 months
High: $32 | Low: $12
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-01 | H.C. WainwrightYi Chen | $26 | 111.6% upside |  |
| 2026-06-22 | Leerink PartnersMani Foroohar | $18 | 46.5% upside | |
| 2026-06-22 | Robert W. BairdBrian Skorney | $32 | 160.4% upside | |
| 2026-05-15 | Morgan Stanley | $16 | 30.2% upside | |
| 2026-05-15 | BarclaysEliana Merle | $12 |  2.4% downside | |
| 2026-03-09 | H.C. Wainwright | $30 | 144.1% upside | |
| 2026-03-05 | Morgan StanleyJudah Frommer | $17 | 38.3% upside | |
| 2026-02-10 | H.C. Wainwright | $32 | 160.4% upside | |
| 2026-02-10 | Robert W. BairdBrian Skorney | $27 | 119.7% upside | |
| 2026-02-10 | UBS | $18 | 46.5% upside | |
| 2026-02-10 | Goldman Sachs | $12 | 2.4% downside | |
| 2026-01-29 | H.C. WainwrightYi Chen | $34 | 176.6% upside | |
| 2026-01-27 | Barclays | $37 | 201.1% upside | |
| 2025-12-19 | Stifel Nicolaus | $45 | 266.2% upside | |
| 2025-12-15 | Leerink PartnersMani Foroohar | $20 | 62.7% upside | |
| 2025-03-18 | Leerink Partners | $24 | 95.3% upside | |
| 2025-01-07 | RBC CapitalLuca Issi | $30 | 144.1% upside | |
| 2024-11-15 | Morgan StanleyJudah Frommer | $22 | 79% upside | |
| 2024-10-10 | Raymond JamesDanielle Brill | $18 | 46.5% upside | |
| 2024-09-05 | H.C. WainwrightYi Chen | $39 | 217.3% upside | |
| 2024-06-24 | Stifel NicolausAnnabel Samimy | $40 | 225.5% upside | |
| 2024-06-07 | Goldman SachsPaul Choi | $38 | 209.2% upside | |
| 2024-05-15 | H.C. WainwrightYi Chen | $38 | 209.2% upside | |
| 2024-03-11 | H.C. WainwrightYi Chen | $36 | 192.9% upside | |
| 2024-03-08 | RBC CapitalLuca Issi | $35 | 184.8% upside | |